Annual Shareholders Equity
$57.02 M
-$133.96 M-70.15%
December 31, 2024
Summary
- As of March 12, 2025, AXSM annual stockholders equity is $57.02 million, with the most recent change of -$133.96 million (-70.15%) on December 31, 2024.
- During the last 3 years, AXSM annual shareholders equity has risen by +$41.38 million (+264.77%).
- AXSM annual shareholders equity is now -70.15% below its all-time high of $190.98 million, reached on December 31, 2023.
Performance
AXSM Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$57.02 M
-$35.88 M-38.63%
December 31, 2024
Summary
- As of March 12, 2025, AXSM quarterly stockholders equity is $57.02 million, with the most recent change of -$35.88 million (-38.63%) on December 31, 2024.
- Over the past year, AXSM quarterly shareholders equity has dropped by -$133.96 million (-70.15%).
- AXSM quarterly shareholders equity is now -79.55% below its all-time high of $278.80 million, reached on June 30, 2023.
Performance
AXSM Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
AXSM Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -70.2% | -70.2% |
| 3 y3 years | +264.8% | -70.2% |
| 5 y5 years | -68.1% | -68.1% |
AXSM Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -70.2% | +264.8% | -79.5% | +287.9% |
| 5 y | 5-year | -70.2% | +264.8% | -79.5% | +287.9% |
| alltime | all time | -70.2% | +1880.3% | -79.5% | +890.6% |
Axsome Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $57.02 M(-70.1%) | $57.02 M(-38.6%) |
| Sep 2024 | - | $92.90 M(-9.7%) |
| Jun 2024 | - | $102.85 M(-28.6%) |
| Mar 2024 | - | $144.04 M(-24.6%) |
| Dec 2023 | $190.98 M(+74.3%) | $190.98 M(-29.1%) |
| Sep 2023 | - | $269.51 M(-3.3%) |
| Jun 2023 | - | $278.80 M(+149.4%) |
| Mar 2023 | - | $111.81 M(+2.1%) |
| Dec 2022 | $109.56 M(+600.9%) | $109.56 M(-30.4%) |
| Sep 2022 | - | $157.36 M(+935.3%) |
| Jun 2022 | - | $15.20 M(+3.4%) |
| Mar 2022 | - | $14.70 M(-6.0%) |
| Dec 2021 | $15.63 M(-86.3%) | $15.63 M(-63.4%) |
| Sep 2021 | - | $42.72 M(-40.2%) |
| Jun 2021 | - | $71.44 M(-25.8%) |
| Mar 2021 | - | $96.29 M(-15.4%) |
| Dec 2020 | $113.79 M(-36.3%) | $113.79 M(-15.9%) |
| Sep 2020 | - | $135.26 M(-12.3%) |
| Jun 2020 | - | $154.24 M(-1.2%) |
| Mar 2020 | - | $156.16 M(-12.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $178.72 M(>+9900.0%) | $178.72 M(+2519.6%) |
| Sep 2019 | - | $6.82 M(-71.9%) |
| Jun 2019 | - | $24.28 M(+39.8%) |
| Mar 2019 | - | $17.37 M(+1752.4%) |
| Dec 2018 | $937.90 K(-94.4%) | $937.90 K(+26.3%) |
| Sep 2018 | - | $742.80 K(-89.4%) |
| Jun 2018 | - | $7.01 M(-44.3%) |
| Mar 2018 | - | $12.59 M(-24.7%) |
| Dec 2017 | $16.72 M(-22.5%) | $16.72 M(-0.7%) |
| Sep 2017 | - | $16.84 M(-26.0%) |
| Jun 2017 | - | $22.75 M(-22.3%) |
| Mar 2017 | - | $29.28 M(+35.7%) |
| Dec 2016 | $21.57 M(-53.6%) | $21.57 M(-23.5%) |
| Sep 2016 | - | $28.18 M(-19.3%) |
| Jun 2016 | - | $34.90 M(-15.4%) |
| Mar 2016 | - | $41.23 M(-11.2%) |
| Dec 2015 | $46.44 M(-1550.2%) | $46.44 M(+1089.8%) |
| Sep 2015 | - | $3.90 M(-154.1%) |
| Jun 2015 | - | -$7.21 M(+125.2%) |
| Dec 2014 | -$3.20 M(+57.9%) | -$3.20 M |
| Dec 2013 | -$2.03 M | - |
FAQ
- What is Axsome Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Axsome Therapeutics?
- What is Axsome Therapeutics annual shareholders equity year-on-year change?
- What is Axsome Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly shareholders equity year-on-year change?
What is Axsome Therapeutics annual stockholders equity?
The current annual shareholders equity of AXSM is $57.02 M
What is the all time high annual shareholders equity for Axsome Therapeutics?
Axsome Therapeutics all-time high annual stockholders equity is $190.98 M
What is Axsome Therapeutics annual shareholders equity year-on-year change?
Over the past year, AXSM annual stockholders equity has changed by -$133.96 M (-70.15%)
What is Axsome Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of AXSM is $57.02 M
What is the all time high quarterly shareholders equity for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly stockholders equity is $278.80 M
What is Axsome Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, AXSM quarterly stockholders equity has changed by -$133.96 M (-70.15%)